Boxer Capital, LLC Cabaletta Bio, Inc. Transaction History

Boxer Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.36 - $14.64 $3.57 Million - $15.6 Million	-1,063,361 Reduced 66.32%	540,000 $2.05 Million
Q4 2020 Feb 16, 2021	BUY	$9.81 - $15.8 $362,970 - $584,600	37,000 Added 2.36%	1,603,361 $20 Million
Q4 2019 Feb 14, 2020	BUY	$7.88 - $17.71 $12.3 Million - $27.7 Million	1,566,361 New	1,566,361 $21.9 Million

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $62.4M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.